Evidence map›Paper›PMID 38042779›Full record

ArticleBMC public health2023

"Easy women get it": pre-existing stigma associated with HPV and cervical cancer in a low-resource setting prior to implementation of an HPV screen-and-treat program.

Rachel M Morse, Joanna Brown, Julia C Gage, Bryn A Prieto, Magdalena Jurczuk, Andrea Matos, Javier Vásquez Vásquez, Reyles Ríos Reátegui, Graciela Meza-Sanchez, Luis Antonio Díaz Córdova and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Rachel M MorseDepartment of Tropical Medicine and Infectious Disease, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
Joanna BrownAsociación Benéfica PRISMA, Lima, Peru.
Julia C GageCenter for Global Health, National Cancer Institute, Bethesda, MD, USA.
Bryn A PrietoDepartment of Tropical Medicine and Infectious Disease, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
Magdalena JurczukDepartment of Tropical Medicine and Infectious Disease, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
Andrea MatosDirección de Prevención y Control de Cancer (DPCAN) of Peruvian Ministry of Health, Lima, Peru.
Javier Vásquez VásquezUniversidad Nacional de la Amazonía Peruana, Iquitos, Peru.
Reyles Ríos ReáteguiUniversidad Nacional de la Amazonía Peruana, Iquitos, Peru.
Graciela Meza-SanchezUniversidad Nacional de la Amazonía Peruana, Iquitos, Peru.
Luis Antonio Díaz CórdovaHospital Regional de Loreto, Iquitos, Peru.
Patti E GravittDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.
J Kathleen TracyDepartment of Medicine, University of Vermont College of Medicine, Burlington, VT, USA.
Valerie A Paz-SoldanDepartment of Tropical Medicine and Infectious Disease, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA. vpazsold@tulane.edu.
Proyecto Precancer Study Group
Tulane University · USUniversidad Nacional de la Amazonía Peruana · PEMinistry of Health · PEPrisma · PECenter for Global Health · USUniversity of Maryland, Baltimore · USUniversity of Vermont · US

Funding

Translating Molecular Diagnostics for Cervical Cancer Prevention into PracticeR01CA190366 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI PAZ-SOLDAN, VALERIE ANDREA, TRACY, J. KATHLEEN · 2016 to 2020
$2.7M
Translating Molecular Diagnostics for Cervical Cancer Prevention into PracticeU01CA190366 · NCI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI PAZ-SOLDAN, VALERIE ANDREA, TRACY, J. KATHLEEN · 2021 to 2025
$2.1M
NCI NIH HHS R01 CA190366NCI NIH HHS U01 CA190366
6 · The paper itself

Abstract

backgroundCervical cancer is preventable with vaccination and early detection and treatment programs. However, for these programs to work as intended, stigma related to HPV and cervical cancer must be understood and addressed. We explored pre-existing stigma associated with HPV and cervical cancer in the public healthcare system and community of a low-resource setting prior to implementation of an HPV screen-and-treat program.

methodsThis study conducted thematic analysis of data collected during implementation of a novel HPV screen-and-treat system for cervical cancer early detection and treatment in Iquitos, Peru. We included 35 semi-structured interviews (19 health professionals, 16 women with cervical precancer or cancer), eight focus groups (70 community women), one workshop (14 health professionals), 210 counseling observations (with 20 nurse-midwives), and a document review. We used the Socio-Ecological Model to organize the analysis.

resultsWe identified three main themes: 1. the implication that women are to blame for their HPV infection through characterizations of being easy or promiscuous, 2. the implication that men are to blame for women's HPV infections through being considered careless or unfaithful, 3. HPV is shameful, embarrassing, and something that should be hidden from others. Consequently, in some cases, women refrained from getting screened for HPV. These themes were seen at the individual level among women, relationship level among women, men, and family members, community level among healthcare staff, and societal level within components of cervical cancer guidelines and male chauvinism.

conclusionsCervical cancer early detection and treatment programs in limited resource settings must address stigma entrenched throughout the entire healthcare system and community in order to sustainably and successfully implement and scale-up new programs. Interventions to tackle this stigma can incorporate messages about HPV infections and latency to lessen the focus on the influence of sexual behavior on HPV acquisition, and instead, promote screening and treatment as paramount preventative measures.

Indexed as

Papillomavirus InfectionsUterine Cervical DysplasiaUterine Cervical NeoplasmsEarly Detection of CancerFemaleFocus GroupsHumansMaleMass ScreeningPapillomaviridaeSocial StigmaCervical cancerHPVScreeningStigma

Identifiers

PMID38042779
PMCPMC10693157
OpenAlexW4389273620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.